Trial Profile
Endothelin in the Coronary Circulation in Early Atherosclerosis in Humans
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Atrasentan (Primary)
- Indications Coronary artery disease
- Focus Pharmacodynamics
- 05 Nov 2010 New trial record.